See, having not heard the audio, I haven't even understood these subgroup findings yet. I'm just going from the written paper announcement. The written announcement was bloody good yesterday, but if there are subgroups who only needed half as much OPT-302 to get a profound response...then this is even better than I first thought.
I wish I could offer antiVEGF-ABCD treatment to some of my patients right now.
This is a really exciting stock
See, having not heard the audio, I haven't even understood...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.010(1.61%) |
Mkt cap ! $404.3M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 60.5¢ | $208.1K | 341.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2890 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 3370 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
61.5¢ |
Change
-0.010 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| 62.0¢ | 62.0¢ | 60.5¢ | 17553 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| OPT (ASX) Chart |